Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pembio is a Swedish biotechnology company that specializes in the high-throughput synthesis and purification of peptides. Founded as a spin-off from the Royal Institute of Technology (KTH) and Uppsala University, the company leverages a proprietary chemical synthesis platform to produce complex and high-purity peptides. Their technology is designed to overcome traditional bottlenecks in peptide production, such as low yields and purity issues with long or difficult sequences. Pembio's offerings support drug discovery, diagnostic development, and academic research by providing reliable access to high-quality peptide tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pembio.